Manon Valiquette - Publications
Affiliations: | Biochemistry and Molecular Medicine | Université de Montréal, Montréal, Canada |
Year | Citation | Score | |||
---|---|---|---|---|---|
2010 | Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Comparing label-free biosensors for pharmacological screening with cell-based functional assays. Assay and Drug Development Technologies. 8: 219-27. PMID 20085460 DOI: 10.1089/adt.2009.0232 | 0.598 | |||
1995 | Valiquette M, Parent S, Loisel TP, Bouvier M. Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor. The Embo Journal. 14: 5542-9. PMID 8521811 DOI: 10.1002/J.1460-2075.1995.Tb00241.X | 0.584 | |||
1995 | Bouvier M, Nantel F, Valiquette M, Moffett S, Mouillac B. Le récepteur β2-adrénergique. Un modèle d'étude des mécanismes moléculaires de la désensibilisation MéDecine/Sciences. 11: 819. DOI: 10.4267/10608/2293 | 0.506 | |||
1993 | Valiquette M, Bonin H, Bouvier M. Mutation of tyrosine-350 impairs the coupling of the beta 2-adrenergic receptor to the stimulatory guanine nucleotide binding protein without interfering with receptor down-regulation. Biochemistry. 32: 4979-85. PMID 8388251 DOI: 10.1021/Bi00070A002 | 0.606 | |||
1990 | Valiquette M, Bonin H, Hnatowich M, Caron MG, Lefkowitz RJ, Bouvier M. Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor. Proceedings of the National Academy of Sciences of the United States of America. 87: 5089-93. PMID 2164220 DOI: 10.1073/Pnas.87.13.5089 | 0.626 | |||
Show low-probability matches. |